+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Contraceptive Patch"

Polycystic ovary syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Polycystic ovary syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028 - Product Thumbnail Image

US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028

  • Report
  • October 2022
  • 300 Pages
  • United States
From
From
Human Reproductive Technologies: Products and Global Markets - Product Thumbnail Image

Human Reproductive Technologies: Products and Global Markets

  • Report
  • July 2022
  • 193 Pages
  • Global
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

The Contraceptive Patch is a transdermal drug delivery system used to prevent pregnancy. It is a small, thin, beige patch that is applied to the skin and releases hormones into the bloodstream. The hormones are absorbed through the skin and prevent ovulation. The patch is worn for one week and then replaced with a new patch. It is a convenient and effective form of contraception. The Contraceptive Patch is part of the larger transdermal and transmucosal drug delivery market. This market includes a variety of drug delivery systems, such as patches, gels, creams, and sprays. These systems are used to deliver drugs to the body through the skin or mucous membranes. They are becoming increasingly popular due to their convenience and effectiveness. Some companies in the Contraceptive Patch market include Mylan, Teva Pharmaceuticals, and Johnson & Johnson. Show Less Read more